#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperadrenocorticism Mitochondrial DNA depletion Bulbospinal muscular atrophy congenital Ovarian cancer stage III Pulmonary hypertension Dedifferentiated liposarcoma Langerhans' cell histiocytosis Trigeminal neuralgia Primary amyloidosis Microvillous inclusion disease Renal disorder Crohn's disease Transient ischaemic attack Burkitt's lymphoma Colitis ulcerative More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Trials in Disease Cystic fibrosis lung – Trials in Disease Vascular malformation – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Shprintzen-Goldberg syndrome Adrenogenital syndrome – Trials in Disease Hepatoblastoma – Basic Information Haemophilia B without inhibitors Angiosarcoma non-metastatic Glycogen storage disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mifamurtide Disodium Folinate HYDROXYCHLOROQUINE Englumafusp Alfa Clofutriben Doravirine Rosuvastatin Calcium Alternaria Alternata (402) Pegaspargase Triamcinolone Hexacetonide Sodium Fluoride (18F) Dexketoprofen Trometamol Ataluren Amg 193 Loncastuximab Tesirine MOLNUPIRAVIR Obicetrapib Diphenhydramine Dinoprostone Tusamitamab Ravtansine More therapies…

    Learn about Your Condition

    Head and neck cancer Type V hyperlipidaemia Vulval cancer Thrombosis Binge eating Hepatic angiosarcoma Aortic aneurysm Dyslipidaemia Uterine leiomyoma Lichen planopilaris Premature baby Hyperinsulinism Torticollis Ovarian cancer recurrent Post procedural hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Rheumatic disorder
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Filgotinib
    • Tofacitinib
    The Netherlands

  • Study of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1

    Recruiting

    3 1 1
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
    Denmark France Germany Italy The Netherlands Spain

  • Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metformin
    • Metformin Hydrochloride
    Germany

  • Study of fixed-dose follitropin delta for ovarian stimulation in women undergoing intrauterine insemination treatment for infertility

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Choriogonadotropin Alfa
    • Dydrogesterone
    • Follitropin Delta
    France

  • Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • RO7837195
    Czechia France Germany Italy Poland

  • Study of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer stage IV
    • Oesophageal carcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Ivonescimab
    • Fluorouracil
    France
Previous Page
1 … 152 153 154 155 156 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!